When activated, these receptors lead to a signalling pathway that increases anti-inflammatory genes and decrease expression of pro-inflammatory transcription factor NF-kB and NADPH oxidase 2 (NOX2) [6], which is up-regulated in the affected brain of CJD patients[49]. The gene discussed is CYBB; the disease is Creutzfeldt Jacob disease.